Iovance Biotherapeutics I... (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

3.35

-0.24 (-6.69%)

At close: May 01, 2025, 3:59 PM

3.38

0.75%

Pre-market: May 02, 2025, 08:55 AM EDT

Iovance Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	115.69M	114.89M	231.73M	78.23M	67.33M	13.97M	82.15M	145.37M	166.47M
Short-Term Investments	208.09M	164.98M	240.11M	426.18M	562.11M	293.11M	386.37M	n/a	59.75M
Long-Term Investments	n/a	n/a	6.43M	91.59M	5.53M	5.45M	n/a	n/a	n/a
Other Long-Term Assets	6.73M	66.7M	-178.25M	7.87M	12.92M	7.44M	2.76M	3.63M	n/a
Receivables	69.34M	151K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	51.52M	10.37M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	12.38M	17.46M	7.27M	3.55M	6.66M	9.41M	6.85M	3.92M	3.04M
Total Current Assets	457.02M	307.85M	471.85M	507.96M	636.1M	312.53M	475.37M	149.29M	169.51M
Property-Plant & Equipment	164.28M	176.54M	178.25M	169.92M	113.92M	19.23M	2.68M	2.45M	2.37M
Goodwill & Intangibles	282.4M	229.26M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	453.41M	472.5M	6.43M	269.38M	132.36M	32.12M	5.45M	6.08M	2.37M
Total Assets	910.43M	780.35M	663.98M	777.33M	768.46M	344.65M	480.82M	155.37M	171.89M
Account Payables	27.51M	33.12M	26.6M	27.38M	13.51M	15.57M	2.74M	1.23M	863K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	12.9M	n/a	12.59M	5.06M	6.28M	7.25M	n/a	n/a	n/a
Other Current Liabilities	81.94M	34.59M	20.3M	30.2M	19.76M	2.15M	7.55M	5.75M	2.52M
Total Current Liabilities	122.34M	110.31M	91.48M	89.2M	54.87M	39.08M	14.4M	9.89M	4.97M
Long-Term Debt	1M	1M	1M	1M	45.38M	4.25M	n/a	n/a	n/a
Other Long-Term Liabilities	44.37M	n/a	n/a	n/a	-33.66M	-1.9M	230K	297K	n/a
Total Long-Term Liabilities	77.68M	85.43M	84.45M	66.47M	57.09M	6.6M	230K	297K	n/a
Total Liabilities	200.02M	195.74M	164.34M	155.67M	111.96M	45.68M	14.63M	9.89M	4.97M
Total Debt	58.26M	75.86M	84.45M	71.53M	51.66M	11.5M	n/a	n/a	n/a
Common Stock	13K	11K	8K	7K	6K	5K	5K	3K	3K
Retained Earnings	-2.38B	-2.01B	-1.57B	-1.17B	-830.19M	-570.61M	-372.76M	-249.18M	-157.12M
Comprehensive Income	-1.05M	2.53M	-902K	-601K	19K	220K	-42K	n/a	29K
Shareholders Equity	710.4M	584.61M	499.64M	621.66M	656.5M	298.97M	466.19M	145.48M	166.92M
Total Investments	208.09M	164.98M	240.11M	517.77M	562.11M	293.11M	386.37M	n/a	59.75M